320 related articles for article (PubMed ID: 28029329)
1. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
[TBL] [Abstract][Full Text] [Related]
3. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
[TBL] [Abstract][Full Text] [Related]
4. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
6. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
Lee AY; Bauersachs R; Janas MS; Jarner MF; Kamphuisen PW; Meyer G; Khorana AA;
BMC Cancer; 2013 Jun; 13():284. PubMed ID: 23764005
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
8. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Noel-Savina E; Sanchez O; Descourt R; André M; Leroyer C; Meyer G; Couturaud F
Thromb Res; 2015 Jan; 135(1):78-83. PubMed ID: 25466839
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.
Kamphuisen PW; Lee AYY; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
J Thromb Haemost; 2018 Jun; 16(6):1069-1077. PubMed ID: 29573330
[TBL] [Abstract][Full Text] [Related]
10. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Louzada M; Carrier M; Tagalakis V; Gross PL; Shivakumar S; Rodger MA; Wells PS
Thromb Res; 2018 Mar; 163():41-46. PubMed ID: 29353682
[TBL] [Abstract][Full Text] [Related]
11. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
[TBL] [Abstract][Full Text] [Related]
12. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
13. OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.
Piatek CI; Tagawa ST; Wei-Tsai D; Hanna D; Weitz IC; O'Connell C; Rochanda L; Groshen S; Liebman HA
Thromb Res; 2016 Apr; 140 Suppl 1():S174. PubMed ID: 27161687
[TBL] [Abstract][Full Text] [Related]
14. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: a meta-analysis of 5 randomized trials in non-cancer and cancer patients.
Laporte S; Bertoletti L; Romera A; Mismetti P; Pérez de Llano LA; Meyer G
Thromb Res; 2012 Dec; 130(6):853-8. PubMed ID: 22939430
[TBL] [Abstract][Full Text] [Related]
16. Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.
Kooiman J; den Exter PL; Kilicsoy I; Cannegieter SC; Eikenboom J; Huisman MV; Klok FA; Versteeg HH
J Thromb Thrombolysis; 2015 Oct; 40(3):323-30. PubMed ID: 25665657
[TBL] [Abstract][Full Text] [Related]
17. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and venous thromboembolism.
Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
20. Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis.
Martínez-Zapata MJ; Mathioudakis AG; Mousa SA; Bauersachs R
Clin Appl Thromb Hemost; 2018 Mar; 24(2):226-234. PubMed ID: 28288527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
